RUBIN PAUL D

BIOA

RUBIN PAUL D serves as officer: Chief Medical Officer at BioAge Labs, Inc. (BIOA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

6 trades

$1.40M

Net Position

Net Seller

$1.40M

Companies Traded

BIOA

Active Period

Dec 2025 – Mar 2026

6 total trades

Most Recent

Sell BIOA

Mar 3, 2026 · $150.9K

RUBIN PAUL D's Insider Trading at BioAge Labs, Inc. (BIOA)

Buys

0 · $0.00

Sells

6 · $1.40M

Total Shares Bought

Total Shares Sold

116,629

BIOA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Mar 3, 2026	Sell	7,433	$20.30	$150.9K
Feb 2, 2026	Sell	7,433	$18.75	$139.4K
Jan 6, 2026	Sell	7,433	$12.85	$95.5K
Jan 2, 2026	Sell	7,433	$12.85	$95.5K
Dec 9, 2025	Sell	18,000	$12.00	$216.0K
Dec 4, 2025	Sell	68,897	$10.19	$701.9K

Related Insiders

Kristen Fortney

director, officer: Chief Executive Officer

BIOASell · Jan 15, 2026

GOLDSTEIN DOV A MD

officer: Chief Financial Officer

BIOASell · Jan 15, 2026

Explore More Insider Trading Data

BIOA Insider Trading Activity

View all insider trades at BioAge Labs, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity